CARDINAL HEALTH INC (CAH:NYSE)
$246.45 -5.09 (-2.0235%)
Analysed CARDINAL HEALTH INC (CAH:NYSE) News Sources
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
22-10-2026
fool.com
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
27-10-2026
fool.com
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
27-10-2026
yahoo.com
Level AI's CX Advisory Board adds Shane Abeyratne, SVP at Cardinal Health
14-10-2026
yahoo.com
Cardinal Health (CAH) Laps the Stock Market: Here's Why
20-10-2026
yahoo.com
Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One
21-10-2026
yahoo.com
IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
21-10-2026
yahoo.com
Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View
22-10-2026
yahoo.com
Should Upcoming Earnings Expectations Require Action From Cardinal Health Stock Investors?
22-10-2026
yahoo.com
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
27-10-2026
yahoo.com
What is the current price of CARDINAL HEALTH INC (CAH:NYSE)?
The current price of CARDINAL HEALTH INC (CAH:NYSE) is $246.45.
CARDINAL HEALTH INC (CAH:NYSE) absolute price change since previous trading day?
The absolute price change of CARDINAL HEALTH INC (CAH:NYSE) since the previous trading day is $-5.09.
CARDINAL HEALTH INC (CAH:NYSE) percentage price change since previous trading day?
The percentage price change of CARDINAL HEALTH INC (CAH:NYSE) since the previous trading day is -2.0235%.
What is the most recent average sentiment score for CARDINAL HEALTH INC (CAH:NYSE)?
The most recent average sentiment score for CARDINAL HEALTH INC (CAH:NYSE) is 70 out of 100.
What is the most recent average sentiment for CARDINAL HEALTH INC (CAH:NYSE)?
The most recent sentiment for CARDINAL HEALTH INC (CAH:NYSE) is .
SEC-8K** Filing Available For CARDINAL HEALTH INC (CAH:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.